TG THERAPEUTICS, INC. (TGTX)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

15 annual periodsNewest to oldest
202520242023202220212020201920182017201620152014201320122011
Revenue$616.3M$329.0M$233.7M$2.8M$6.7M$152,000$152,000$152,000$152,000$152,000
Research & development$160.2M$94.3M$76.2M$125.4M$222.6M$165.9M$154.2M$159.4M$102.5M$69.2M$47.7M$40.1M$13.7M$21.0M$327,283
Operating expenses$195.6M$351.5M$273.7M$169.2M$174.6M$118.9M$79.1M$63.3M$55.9M$23.1M$26.9M$881,974
Operating income$123.3M$41.9M$20.6M−$218.3M−$344.8M−$273.6M−$169.1M−$174.4M−$118.7M−$79.0M−$63.2M−$55.7M−$23.0M−$26.9M−$881,974
EBITDAderived$123.4M$42.0M$20.8M−$218.0M−$344.5M−$273.2M−$168.8M
Net income$447.2M$23.4M$12.7M−$223.8M−$348.1M−$279.4M−$172.9M−$173.5M−$118.5M−$78.3M−$62.9M−$55.8M−$20.5M−$18.1M−$853,074
Basic EPSper diluted share$3.10$0.16$0.09-$1.65-$2.63-$2.42-$1.96-$2.30-$1.91-$1.60-$1.38-$1.64-$0.81-$1.38-$0.44
Diluted EPSper diluted share$2.77$0.15$0.09-$1.65-$2.63-$2.42-$1.96-$2.30-$1.91-$1.60-$1.38-$1.64-$0.81-$1.38-$0.44

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)8$3.23M disclosed value
8 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Nov 24, 2025Form 4Echelard YannDirectorSellCommon Stock5.0K$32.57$162.8K223.8K
Sep 11, 2025Form 4Lonial SagarDirectorSellCommon Stock20.9K$32.24$672.3K94.1K
Jun 13, 2025Form 4Echelard YannDirectorSellCommon Stock10.0K$36.94$369.4K228.8K
Jan 6, 2025Form 4Power Sean ACFOSellCommon Stock10.0K$28.53$285.9K660.6K
Jan 3, 2025Form 4Power Sean ACFOSellCommon Stock11.3K$30.29$343.4K670.6K